Published in Clin Exp Hypertens on April 19, 2005
Telmisartan/hydrochlorothiazide versus valsartan/hydrochlorothiazide in obese hypertensive patients with type 2 diabetes: the SMOOTH study. Cardiovasc Diabetol (2007) 0.90
Should 24-h ambulatory blood pressure monitoring be done in every patient with diabetes? Diabetes Care (2009) 0.88
Differences in circadian time structure of diastolic blood pressure between diabetes mellitus and essential hypertension. Diabetol Metab Syndr (2012) 0.75
Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest (2002) 12.22
A case-control study of calciphylaxis in Japanese end-stage renal disease patients. Nephrol Dial Transplant (2011) 3.49
Model-guided microarray implicates the retromer complex in Alzheimer's disease. Ann Neurol (2005) 3.01
Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis. Nat Med (2012) 2.44
Effect of angiotensin receptor blockers on cardiovascular events in patients undergoing hemodialysis: an open-label randomized controlled trial. Am J Kidney Dis (2008) 2.39
Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin. J Clin Invest (2004) 2.24
Systemic capillary leak syndrome. Intern Med (2002) 1.88
Recommendations on the management of encapsulating peritoneal sclerosis in Japan, 2005: diagnosis, predictive markers, treatment, and preventive measures. Perit Dial Int (2005) 1.78
Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD. Am J Kidney Dis (2004) 1.69
Overview of regular dialysis treatment in Japan (as of 31 December 2008). Ther Apher Dial (2010) 1.62
Bradykinin decreases plasminogen activator inhibitor-1 expression and facilitates matrix degradation in the renal tubulointerstitium under angiotensin-converting enzyme blockade. J Am Soc Nephrol (2004) 1.61
Connective tissue growth factor expressed in tubular epithelium plays a pivotal role in renal fibrogenesis. J Am Soc Nephrol (2004) 1.53
Crossover study of amlodipine versus nifedipine CR with home blood pressure monitoring via cellular phone: internet-mediated open-label crossover trial of calcium channel blockers for hypertension (i-TECHO trial). J Hypertens (2007) 1.42
A five-year comparison of the renal protective effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with non-diabetic nephropathy. Intern Med (2006) 1.41
Noninvasive evaluation of kidney hypoxia and fibrosis using magnetic resonance imaging. J Am Soc Nephrol (2011) 1.41
Impact of selectin gene polymorphisms on rapid progression to end-stage renal disease in patients with IgA nephropathy. Intern Med (2006) 1.39
An overview of regular dialysis treatment in Japan (as of 31 December 2010). Ther Apher Dial (2012) 1.37
Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a Phase III, randomized, double-blind, placebo-controlled study. Nephrol Dial Transplant (2009) 1.31
Overview of regular dialysis treatment in Japan (as of 31 December 2011). Ther Apher Dial (2013) 1.29
Qualification of arterial stiffness as a risk factor to the progression of chronic kidney diseases. Am J Nephrol (2005) 1.15
Overview of regular dialysis treatment in Japan as of 31 December 2006. Ther Apher Dial (2008) 1.14
Continuous hemodiafiltration with polymyxin-B immobilized fiber is effective in patients with sepsis syndrome and acute renal failure. Ther Apher (2002) 1.13
Effects of candesartan on cardiovascular outcomes in Japanese hypertensive patients. Hypertens Res (2005) 1.13
Overview of regular dialysis treatment in Japan (as of 31 December 2009). Ther Apher Dial (2012) 1.11
An overview of regular dialysis treatment in Japan (as of 31 December 2012). Ther Apher Dial (2014) 1.11
Effects of icodextrin on glycemic and lipid profiles in diabetic patients undergoing peritoneal dialysis. Am J Nephrol (2007) 1.08
Efficacy and safety of a novel ĸ-agonist for managing intractable pruritus in dialysis patients. Am J Nephrol (2012) 1.03
Low doses of losartan and trandolapril improve arterial stiffness in hemodialysis patients. Am J Kidney Dis (2005) 1.03
Risk factors and cause of removal of peritoneal dialysis catheter in patients on continuous ambulatory peritoneal dialysis. Adv Perit Dial (2008) 1.01
Searching for the reasons for drop-out from peritoneal dialysis: a nationwide survey in Japan. Perit Dial Int (2003) 0.99
BACE1 retrograde trafficking is uniquely regulated by the cytoplasmic domain of sortilin. J Biol Chem (2011) 0.98
An overview of regular dialysis treatment in Japan (as of 31 December 2007). Ther Apher Dial (2009) 0.98
Transient receptor potential channels in rat renal microcirculation: actions of angiotensin II. Kidney Int (2002) 0.97
Fibroblast expression of an IκB dominant-negative transgene attenuates renal fibrosis. J Am Soc Nephrol (2010) 0.97
Key role of insulin resistance in vascular injury among hemodialysis patients. Metabolism (2007) 0.95
Short- and long-term prognosis of blood pressure and kidney disease in women with a past history of preeclampsia. Clin Exp Nephrol (2008) 0.92
Connective tissue growth factor mediates the profibrotic effects of transforming growth factor-beta produced by tubular epithelial cells in response to high glucose. Clin Exp Nephrol (2005) 0.91
Ultrasonographic observation of the healing process in the gap after a Ponseti-type Achilles tenotomy for idiopathic congenital clubfoot at two-year follow-up. J Orthop Sci (2012) 0.91
Connexins 37 and 40 transduce purinergic signals mediating renal autoregulation. Am J Physiol Regul Integr Comp Physiol (2007) 0.90
Granulomatous interstitial nephritis in chronic lymphocytic leukaemia. Nephrol Dial Transplant (2010) 0.89
A selective angiotensin receptor antagonist, Valsartan, produced regression of left ventricular hypertrophy associated with a reduction of arterial stiffness. Adv Perit Dial (2003) 0.89
Outcome of medial displacement calcaneal osteotomy for correction of adult-acquired flatfoot. Foot Ankle Int (2012) 0.88
Overview of regular dialysis treatment in Japan (as of 31 December 2005). Ther Apher Dial (2007) 0.88
Dexamethasone induces connective tissue growth factor expression in renal tubular epithelial cells in a mouse strain-specific manner. Am J Pathol (2006) 0.88
A possible anti-inflammatory role of angiotensin II type 2 receptor in immune-mediated glomerulonephritis during type 1 receptor blockade. Am J Pathol (2006) 0.88
Dopamine D1-like receptor antagonist attenuates Th17-mediated immune response and ovalbumin antigen-induced neutrophilic airway inflammation. J Immunol (2011) 0.88
Frequency of anti-heparin-PF4 complex antibodies (HIT antibodies) in uremic patients on chronic intermittent hemodialysis. Pathophysiol Haemost Thromb (2006) 0.87
Anandamide decreases glomerular filtration rate through predominant vasodilation of efferent arterioles in rat kidneys. J Am Soc Nephrol (2004) 0.87
Angiotensin II type 1 receptor blockade attenuates renal fibrogenesis in an immune-mediated nephritic kidney through counter-activation of angiotensin II type 2 receptor. Biochem Biophys Res Commun (2004) 0.87
An angiotensin receptor blocker reduces the risk of congestive heart failure in elderly hypertensive patients with renal insufficiency. Hypertens Res (2005) 0.86
Selective depletion of fibroblasts preserves morphology and the functional integrity of peritoneum in transgenic mice with peritoneal fibrosing syndrome. Kidney Int (2003) 0.86
Effect of Achilles tenotomy on congenital clubfoot-associated calf-muscle atrophy: an ultrasonographic study. J Orthop Sci (2013) 0.85
Comparison and survival of patients receiving hemodialysis and peritoneal dialysis in a single center. Adv Perit Dial (2007) 0.85
[Two cases of incidentally detected renal arteriovenous fistula over ten years after renal biopsy]. Nihon Jinzo Gakkai Shi (2016) 0.84
Continuous ambulatory peritoneal dialysis is effective for patients with severe congestive heart failure. Adv Perit Dial (2006) 0.83
Efficacy and safety of meropenem plus tobramycin followed by meropenem plus vancomycin for treating peritonitis in patients on continuous ambulatory peritoneal dialysis. Adv Perit Dial (2006) 0.83
Tubular expression of connective tissue growth factor correlates with interstitial fibrosis in type 2 diabetic nephropathy. Nephrol Dial Transplant (2005) 0.83
An atypical pattern of Epstein-Barr virus infection in a case with idiopathic tubulointerstitial nephritis. Nephron (2002) 0.83
Prospective multicenter observational study of encapsulating peritoneal sclerosis with neutral dialysis solution--the NEXT-PD study. Adv Perit Dial (2010) 0.82
Effects of endocrine disrupting substance on estrogen receptor gene transcription in dialysis patients. Ther Apher Dial (2007) 0.82
Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy. Ther Apher Dial (2004) 0.82
Transgene-derived hepatocyte growth factor attenuates reactive renal fibrosis in aristolochic acid nephrotoxicity. Nephrol Dial Transplant (2003) 0.81
A new classification of Diabetic Nephropathy 2014: a report from Joint Committee on Diabetic Nephropathy. Clin Exp Nephrol (2015) 0.81
The newly developed calcium antagonist, azelnidipine, increases drain volume in continuous ambulatory peritoneal dialysis patients. Adv Perit Dial (2006) 0.81
TGF-beta1 and HGF coordinately facilitate collagen turnover in subepithelial mesenchyme. Biochem Biophys Res Commun (2002) 0.81
Participation of bone marrow cells in biliary fibrosis after bile duct ligation. J Gastroenterol Hepatol (2007) 0.81
Aging is an important risk factor for peritoneal dialysis-associated peritonitis. Adv Perit Dial (2012) 0.81
Interstitial fibroblast-like cells express renin-angiotensin system components in a fibrosing murine kidney. Am J Pathol (2002) 0.81
Absence of increased alpha1-microglobulin in IgA nephropathy proteinuria. Mol Cell Proteomics (2007) 0.81
Effects of eplerenone on heart and kidney in two-kidney, one-clip rats. Am J Nephrol (2003) 0.81
Angiotensin II type 2 receptor inhibits prorenin processing in juxtaglomerular cells. Hypertens Res (2003) 0.81
A case report suggesting the occurrence of epithelial-mesenchymal transition in obstructive nephropathy. Clin Exp Nephrol (2009) 0.80